Trial NCT01273064

View at ClinicalTrials.gov 
Org. Study IDs: CTS-1027-05

Last trial update was posted on 2012-06-11

MeSH Interventions

Interferons Ribavirin

MeSH Conditions

Hepatitis Hepatitis A Hepatitis C

Other Conditions


Stopping Reasons

Risk-benefit ratio

Limitations And Caveats

This study was terminated early after 3 reports of hyperbilirubinemia occurred(2 on 60mg bid and 1 on 30mg bid of CTS 1027). Two incidents were reported as part of an SAE. The risk/benefit ratio did not warrant further continuation of the study.

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID